Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Factors Associated with Adherence to the HEDIS Quality Measure in Medicaid Patients with Schizophrenia.

Lafeuille MH, Frois C, Cloutier M, Duh MS, Lefebvre P, Pesa J, Clancy Z, Fastenau J, Durkin M.

Am Health Drug Benefits. 2016 Oct;9(7):399-410.

2.

Genetic factor common to schizophrenia and HIV infection is associated with risky sexual behavior: antagonistic vs. synergistic pleiotropic SNPs enriched for distinctly different biological functions.

Wang Q, Polimanti R, Kranzler HR, Farrer LA, Zhao H, Gelernter J.

Hum Genet. 2017 Jan;136(1):75-83. doi: 10.1007/s00439-016-1737-8.

PMID:
27752767
3.
4.

Validation of the UCSD Performance-based Skills Assessment (UPSA) in Hispanics with and without schizophrenia.

Mausbach BT, Tiznado D, Cardenas V, Jeste DV, Patterson TL.

Psychiatry Res. 2016 Oct 30;244:388-93. doi: 10.1016/j.psychres.2016.08.027.

PMID:
27525829
5.

Metabolic Abnormalities in the Hippocampus of Patients with Schizophrenia: A 3D Multivoxel MR Spectroscopic Imaging Study at 3T.

Meyer EJ, Kirov II, Tal A, Davitz MS, Babb JS, Lazar M, Malaspina D, Gonen O.

AJNR Am J Neuroradiol. 2016 Dec;37(12):2273-2279.

PMID:
27444940
6.

Transition to Psychosis: Evaluation of the First-Degree Relatives of Patients with Schizophrenia ‎.

Hormozpour M, Amini H, Pajouhanfar S, Faghankhani M, Rahmani A, Sharifi V.

Iran J Psychiatry. 2016 Jan;11(1):15-23.

7.

Sociocultural Factors Associated with Caregiver-Psychiatrist Relationship in Taiwan.

Wu HC, Chen FP.

Psychiatry Investig. 2016 May;13(3):288-96. doi: 10.4306/pi.2016.13.3.288.

8.

Hospitalization and cost after switching from atypical to typical antipsychotics in schizophrenia patients in Thailand.

Boonlue T, Subongkot S, Dilokthornsakul P, Kongsakon R, Pattanaprateep O, Suanchang O, Chaiyakunapruk N.

Clinicoecon Outcomes Res. 2016 Apr 29;8:127-36. doi: 10.2147/CEOR.S97300.

9.

Inpatient resource use and costs associated with switching from oral antipsychotics to aripiprazole once-monthly for the treatment of schizophrenia.

Wilson M, Gutierrez B, Offord SJ, Blanchette CM, Eramo A, Earnshaw S, Kamat SA.

Drugs Context. 2016 Mar 11;5:212273. doi: 10.7573/dic.212273.

10.

RNA Sequencing in Schizophrenia.

Li X, Teng S.

Bioinform Biol Insights. 2016 Mar 31;9(Suppl 1):53-60. doi: 10.4137/BBI.S28992. Review.

11.

Global economic burden of schizophrenia: a systematic review.

Chong HY, Teoh SL, Wu DB, Kotirum S, Chiou CF, Chaiyakunapruk N.

Neuropsychiatr Dis Treat. 2016 Feb 16;12:357-73. doi: 10.2147/NDT.S96649. Review.

12.

Perspectives on the Use of eHealth in the Management of Patients With Schizophrenia.

Treisman GJ, Jayaram G, Margolis RL, Pearlson GD, Schmidt CW, Mihelish GL, Kennedy A, Howson A, Rasulnia M, Misiuta IE.

J Nerv Ment Dis. 2016 Aug;204(8):620-9. doi: 10.1097/NMD.0000000000000471.

13.
14.

Conceptualization and treatment of negative symptoms in schizophrenia.

Sarkar S, Hillner K, Velligan DI.

World J Psychiatry. 2015 Dec 22;5(4):352-61. doi: 10.5498/wjp.v5.i4.352.

15.

The Promises and Challenges of Ecological Momentary Assessment in Schizophrenia: Development of an Initial Experimental Protocol.

Gaudiano BA, Moitra E, Ellenberg S, Armey MF.

Healthcare (Basel). 2015 Sep;3(3):556-73. doi: 10.3390/healthcare3030556.

16.
17.

Preparation, Characterization, and In Vivo Evaluation of Olanzapine Poly(D,L-lactide-co-glycolide) Microspheres.

D'Souza S, Faraj JA, Giovagnoli S, DeLuca PP.

J Pharm (Cairo). 2013;2013:831381. doi: 10.1155/2013/831381.

18.

The Early Psychosis Intervention Center (EPICENTER): development and six-month outcomes of an American first-episode psychosis clinical service.

Breitborde NJ, Bell EK, Dawley D, Woolverton C, Ceaser A, Waters AC, Dawson SC, Bismark AW, Polsinelli AJ, Bartolomeo L, Simmons J, Bernstein B, Harrison-Monroe P.

BMC Psychiatry. 2015 Oct 28;15:266. doi: 10.1186/s12888-015-0650-3.

19.

Antipsychotic Maintenance Treatment: Time to Rethink?

Moncrieff J.

PLoS Med. 2015 Aug 4;12(8):e1001861. doi: 10.1371/journal.pmed.1001861.

20.

Nonlinear parameters of surface EMG in schizophrenia patients depend on kind of antipsychotic therapy.

Meigal AY, Miroshnichenko GG, Kuzmina AP, Rissanen SM, Georgiadis SD, Karjalainen PA.

Front Physiol. 2015 Jul 10;6:197. doi: 10.3389/fphys.2015.00197.

Items per page

Supplemental Content

Support Center